{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:20:19Z","timestamp":1793175619400,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"crossref","award":["RIA2017S"],"award-info":[{"award-number":["RIA2017S"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"crossref","award":["RIA2017S"],"award-info":[{"award-number":["RIA2017S"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-22010-5","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T12:39:40Z","timestamp":1761914380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Decision-making and acceptability of subcutaneously administered broadly neutralising monoclonal antibodies for HIV prevention amongst CAPRISA 012A trial participants in Durban, South Africa"],"prefix":"10.1038","volume":"15","author":[{"given":"Hilton","family":"Humphries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hlengi","family":"Shozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimasa","family":"Tshawe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makhosazane","family":"Mdladla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandisa","family":"Msomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Chetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nqobile","family":"Myeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishana","family":"Harkoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim Abdool","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharana","family":"Mahomed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"22010_CR1","unstructured":"UNAIDS. 2024 global AIDS report\u2014The Urgency of Now: AIDS at a Crossroads. 2024. Available from: https:\/\/crossroads.unaids.org"},{"issue":"12","key":"22010_CR2","doi-asserted-by":"publisher","first-page":"e0279289","DOI":"10.1371\/journal.pone.0279289","volume":"17","author":"L Lewis","year":"2022","unstructured":"Lewis, L. et al. HIV incidence and associated risk factors in adolescent girls and young women in South Africa: A population-based cohort study. PLoS One Internet 17(12), e0279289 (2022).","journal-title":"PLoS One Internet"},{"key":"22010_CR3","unstructured":"Zuma, K., Zungu, N.P., Moyo, S., Marinda, E., Simbayi, L.C. & Jooste, S.E. et al. The Sixth South African National HIV Prevalence, Incidence and Behaviour Survey, 2022: A Summary Report. Cape Town (2024)."},{"issue":"1","key":"22010_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/COH.0000000000000207","volume":"11","author":"KA Thomson","year":"2016","unstructured":"Thomson, K. A. et al. Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women. Curr. Opin. HIV AIDS 11(1), 18\u201326 (2016).","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"2","key":"22010_CR5","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1016\/S2352-3018(17)30156-X","volume":"5","author":"LGG Bekker","year":"2017","unstructured":"Bekker, L. G. G. et al. Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067\/ADAPT Cape Town trial): A randomised, open-label, phase 2 trial. Lancet HIV 5(2), e68-78 (2017).","journal-title":"Lancet HIV"},{"issue":"22","key":"22010_CR6","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","volume":"375","author":"JM Baeten","year":"2016","unstructured":"Baeten, J. M. et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. New Engl. J. Med. Internet 375(22), 2121\u20132132 (2016).","journal-title":"New Engl. J. Med. Internet"},{"issue":"22","key":"22010_CR7","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","volume":"375","author":"A Nel","year":"2016","unstructured":"Nel, A. et al. Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women. N Engl J Med. Internet 375(22), 2133\u20132143 (2016).","journal-title":"N Engl J Med. Internet"},{"key":"22010_CR8","unstructured":"AVAC. https:\/\/www.prepwatch.org\/countries\/south-africa\/. PrEP Watch: Country Overview: South Africa. (2025)."},{"issue":"1","key":"22010_CR9","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.4102\/sajhivmed.v23i1.1405","volume":"23","author":"LG Bekker","year":"2022","unstructured":"Bekker, L. G. et al. Oral pre-exposure prophylaxis uptake, adherence, and adverse events among South African men who have sex with men and transgender women. South Afr. J. HIV Med. 23(1), 1405. https:\/\/doi.org\/10.4102\/sajhivmed.v23i1.1405 (2022).","journal-title":"South Afr. J. HIV Med."},{"key":"22010_CR10","first-page":"48","volume":"1","author":"L Nkosi","year":"2024","unstructured":"Nkosi, L., Mmem, Q. D., Tsafa, T. N., Gwar, J. N. & Agaku, I. T. Awareness and openness to using PrEP among a nationally representative sample of south African adults. Pan Afr. Med. J. 1, 48 (2024).","journal-title":"Pan Afr. Med. J."},{"key":"22010_CR11","unstructured":"UNAIDS. Women and HIV: A spotlight on adolescent girls and young women. 1\u201320 (2019)."},{"issue":"13","key":"22010_CR12","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa2407001","volume":"391","author":"LG Bekker","year":"2024","unstructured":"Bekker, L. G. et al. Twice-Yearly Lenacapavir or Daily F\/TAF for HIV Prevention in Cisgender Women. N. Engl. J. Med. 391(13), 1179\u20131192 (2024).","journal-title":"N. Engl. J. Med."},{"key":"22010_CR13","doi-asserted-by":"publisher","unstructured":"Pike, C., Rousseau, E. & Bekker, L.-G. Promises and potential pitfalls of long-acting injectable pre-exposure prophylaxis. South Afr. J. HIV Med. 24(1). https:\/\/doi.org\/10.4102\/sajhivmed.v24i1.1497 (2023).","DOI":"10.4102\/sajhivmed.v24i1.1497"},{"key":"22010_CR14","unstructured":"IAVI. Evolving access pathways for long-acting HIV prevention products [Internet]. 2021. Available from: https:\/\/www.iavi.org\/phocadownload\/Access-pathways-for-long-acting-HIV-prevention-products.pdf"},{"key":"22010_CR15","first-page":"102870","volume":"46","author":"H Humphries","year":"2024","unstructured":"Humphries, H., Knight, L. & van Heerden, A. The HIV prevention decision-making cascade: Integrating behavioural insights into HIV prevention efforts. Prev. Med. Rep. Internet 46, 102870 (2024).","journal-title":"Prev. Med. Rep. Internet"},{"key":"22010_CR16","doi-asserted-by":"publisher","first-page":"S230","DOI":"10.1097\/QAI.0000000000002216","volume":"82","author":"LK Beres","year":"2019","unstructured":"Beres, L. K. et al. Human-centered design lessons for implementation science: Improving the implementation of a patient-centered care intervention. J. Acquir. Immun. Defic. Syndr. 82, S230\u2013S243 (2019).","journal-title":"J. Acquir. Immun. Defic. Syndr."},{"issue":"1","key":"22010_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12913-022-07577-3","volume":"22","author":"M Sekhon","year":"2022","unstructured":"Sekhon, M., Cartwright, M. & Francis, J. J. Development of a theory-informed questionnaire to assess the acceptability of healthcare interventions. BMC Health Serv. Res. 22(1), 279. https:\/\/doi.org\/10.1186\/s12913-022-07577-3 (2022).","journal-title":"BMC Health Serv. Res."},{"key":"22010_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17437199.2012.654964","volume":"6","author":"S Michie","year":"2012","unstructured":"Michie, S. & Johnston, M. Theories and techniques of behaviour change: Developing a cumulative science of behaviour change. Health Psychol. Rev. 6, 1\u20136 (2012).","journal-title":"Health Psychol. Rev."},{"key":"22010_CR19","doi-asserted-by":"crossref","unstructured":"West R, Michie S. A brief introduction to the COM-B Model of behaviour and the PRIME Theory of motivation. Qeios. (2020)","DOI":"10.32388\/WW04E6.2"},{"issue":"8","key":"22010_CR20","doi-asserted-by":"publisher","first-page":"308","DOI":"10.12688\/wellcomeopenres.19363.1","volume":"17","author":"MM Marques","year":"2023","unstructured":"Marques, M. M. et al. The Behaviour Change Technique Ontology: Transforming the Behaviour Change Technique Taxonomy v1. Wellcome Open Res. 17(8), 308 (2023).","journal-title":"Wellcome Open Res."},{"issue":"3","key":"22010_CR21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/infdis\/jiac041","volume":"226","author":"S Mahomed","year":"2022","unstructured":"Mahomed, S. et al. Safety and pharmacokinetics of monoclonal antibodies VRC07-523LS and PGT121 administered subcutaneously for human immunodeficiency virus prevention. J. Infect. Dis. Internet 226(3), 510\u2013520 (2022).","journal-title":"J. Infect. Dis. Internet"},{"issue":"1","key":"22010_CR22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12913-017-2031-8","volume":"17","author":"M Sekhon","year":"2017","unstructured":"Sekhon, M., Cartwright, M. & Francis, J. J. Acceptability of healthcare interventions: An overview of reviews and development of a theoretical framework. BMC Health Serv Res. 17(1), 88 (2017).","journal-title":"BMC Health Serv Res."},{"key":"22010_CR23","unstructured":"Boyatzis RE. Transforming qualitative information: Thematic analysis and code development. Transforming qualitative information: Thematic analysis and code development. Thousand Oaks, CA, US: Sage Publications, Inc. xvi, 184\u2013xvi, 184.(1998)."},{"key":"22010_CR24","unstructured":"Strauss, A. & Corbin, J. Grounded Theory Methodology: AN Overview. In: Handbook of Qualitative Research. (1998)."},{"issue":"9","key":"22010_CR25","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1007\/s10461-020-02808-2","volume":"24","author":"EE Tolley","year":"2020","unstructured":"Tolley, E. E. et al. Acceptability of long-acting injectable cabotegravir (CAB LA) in HIV-uninfected individuals: HPTN 077. AIDS Behav. 24(9), 2520\u20132531. https:\/\/doi.org\/10.1007\/s10461-020-02808-2 (2020).","journal-title":"AIDS Behav."},{"issue":"10","key":"22010_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jia2.25408","volume":"22","author":"EE Tolley","year":"2019","unstructured":"Tolley, E. E. et al. Acceptability of a long-acting injectable HIV prevention product among US and African women: Findings from a phase 2 clinical Trial (HPTN 076). J. Int. AIDS Soc. 22(10), 1\u20139 (2019).","journal-title":"J. Int. AIDS Soc."},{"issue":"1","key":"22010_CR27","doi-asserted-by":"publisher","first-page":"e0262043","DOI":"10.1371\/journal.pone.0262043","volume":"17","author":"H Humphries","year":"2022","unstructured":"Humphries, H. et al. Implants for HIV prevention in young women: Provider perceptions and lessons learned from contraceptive implant provision. PLoS ONE 17(1), e0262043 (2022).","journal-title":"PLoS ONE"},{"issue":"8","key":"22010_CR28","first-page":"693","volume":"53","author":"RN Carey","year":"2018","unstructured":"Carey, R. N. et al. Behavior change techniques and their mechanisms of action: A synthesis of links described in published intervention literature. Ann. Behav. Med. 53(8), 693\u2013707 (2018).","journal-title":"Ann. Behav. Med."},{"issue":"8","key":"22010_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/abm\/kay082","volume":"53","author":"LE Connell","year":"2019","unstructured":"Connell, L. E. et al. Links between behaviour change techniques and mechanisms of action: An expert consensus study. Ann. Behav. Med. 53(8), 708\u2013720. https:\/\/doi.org\/10.1093\/abm\/kay082 (2019).","journal-title":"Ann. Behav. Med."},{"issue":"1","key":"22010_CR30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12889-023-15260-3","volume":"23","author":"R Nabunya","year":"2023","unstructured":"Nabunya, R., Karis, V. M. S., Nakanwagi, L. J., Mukisa, P. & Muwanguzi, P. A. Barriers and facilitators to oral PrEP uptake among high-risk men after HIV testing at workplaces in Uganda: A qualitative study. BMC Public Health 23(1), 365. https:\/\/doi.org\/10.1186\/s12889-023-15260-3 (2023).","journal-title":"BMC Public Health"},{"issue":"1","key":"22010_CR31","first-page":"1","volume":"3","author":"KT Bond","year":"2016","unstructured":"Bond, K. T. & Gunn, A. J. Perceived advantages and disadvantages of using pre-exposure prophylaxis (PrEP) among sexually active black women: An exploratory study. J. Black Sex Relatsh. 3(1), 1\u201324 (2016).","journal-title":"J. Black Sex Relatsh."},{"issue":"2","key":"22010_CR32","first-page":"255","volume":"8","author":"RW Eisinger","year":"2019","unstructured":"Eisinger, R. W., Folkers, G. K. & Fauci, A. S. Ending the HIV pandemic: Optimizing the prevention and treatment toolkits. Clin. Infect. Dis. 8(2), 255\u2013256 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"22010_CR33","unstructured":"AVAC. Lessons From Oral PrEP Programs And Their Implications for Next Generation Prevention. (2021)"},{"key":"22010_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.socscimed.2015.09.039","volume":"146","author":"E Fearon","year":"2015","unstructured":"Fearon, E., Wiggins, R. D., Pettifor, A. E. & Hargreaves, J. R. Is the sexual behaviour of young people in sub-Saharan Africa influenced by their peers? A systematic review. Soc. Sci. Med. 146, 62\u201374 (2015).","journal-title":"Soc. Sci. Med."},{"issue":"2","key":"22010_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10461-010-9802-0","volume":"14","author":"BR Karney","year":"2010","unstructured":"Karney, B. R. et al. A framework for incorporating dyads in models of HIV-prevention. AIDS Behav. 14(2), 189\u2013203. https:\/\/doi.org\/10.1007\/s10461-010-9802-0 (2010).","journal-title":"AIDS Behav."},{"issue":"209","key":"22010_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.socscimed.2018.05.024","volume":"1","author":"IS Speizer","year":"2018","unstructured":"Speizer, I. S. et al. Changing sex risk behaviors, gender norms, and relationship dynamics among couples in Cape Town, south Africa: Efficacy of an intervention on the dyad. Soc. Sci. Med. 1(209), 95\u2013103 (2018).","journal-title":"Soc. Sci. Med."},{"issue":"1","key":"22010_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/COH.0000000000000773","volume":"18","author":"A Van Heerden","year":"2022","unstructured":"Van Heerden, A., Humphries, H. & Geng, E. Whole person HIV services: A social science approach. Curr Opin HIV AIDS 18(1), 46\u201351. https:\/\/doi.org\/10.1097\/COH.0000000000000773 (2022).","journal-title":"Curr Opin HIV AIDS"},{"issue":"4","key":"22010_CR38","doi-asserted-by":"publisher","first-page":"e0195107","DOI":"10.1371\/journal.pone.0195107","volume":"13","author":"H Humphries","year":"2018","unstructured":"Humphries, H., Osman, F., Knight, L. & Abdool, K. Q. Exploratory analysis of the ecological variables associated with sexual health profiles in high-risk, sexually-active female learners in rural KwaZulu-Natal. PLoS ONE 13(4), e0195107 (2018).","journal-title":"PLoS ONE"},{"issue":"9","key":"22010_CR39","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/17441692.2021.1969672","volume":"17","author":"H Humphries","year":"2022","unstructured":"Humphries, H. et al. Exploring discrepant knowledge of partner sexual behaviour to inform self-risk assessment in a high HIV burdened district in rural KwaZulu-Natal. Glob. Public Health 17(9), 2054\u20132069 (2022).","journal-title":"Glob. Public Health"},{"issue":"1","key":"22010_CR40","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10461-024-04529-2","volume":"29","author":"W Makoni","year":"2024","unstructured":"Makoni, W. et al. HIV prevention product acceptability and preference among women in sub-Saharan Africa to inform novel biomedical options in development: A systematic review. AIDS Behav. 29(1), 257\u2013293. https:\/\/doi.org\/10.1007\/s10461-024-04529-2 (2024).","journal-title":"AIDS Behav."},{"issue":"1","key":"22010_CR41","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12879-018-3463-4","volume":"18","author":"D Sidebottom","year":"2018","unstructured":"Sidebottom, D., Ekstr\u00f6m, A. M. & Str\u00f6mdahl, S. A systematic review of adherence to oral pre-exposure prophylaxis for HIV\u2014How can we improve uptake and adherence? BMC Infect. Dis. 18(1), 581. https:\/\/doi.org\/10.1186\/s12879-018-3463-4 (2018).","journal-title":"BMC Infect. Dis."},{"issue":"6","key":"22010_CR42","doi-asserted-by":"publisher","first-page":"e0198680","DOI":"10.1371\/journal.pone.0198680","volume":"13","author":"EA Warren","year":"2018","unstructured":"Warren, E. A. et al. Risk perception and the influence on uptake and use of biomedical prevention interventions for HIV in sub-Saharan Africa: A systematic literature review. PLoS ONE 13(6), e0198680. https:\/\/doi.org\/10.1371\/journal.pone.0198680 (2018).","journal-title":"PLoS ONE"},{"issue":"1","key":"22010_CR43","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/1471-2458-13-220","volume":"13","author":"M Musheke","year":"2013","unstructured":"Musheke, M. et al. A systematic review of qualitative findings on factors enabling and deterring uptake of HIV testing in sub-Saharan Africa. BMC Public Health 13(1), 220 (2013).","journal-title":"BMC Public Health"},{"key":"22010_CR44","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s44159-024-00305-0","volume":"3","author":"D Albarrac\u00edn","year":"2024","unstructured":"Albarrac\u00edn, D., Fayaz-Farkhad, B. & Granados Samayoa, J. A. Determinants of behaviour and their efficacy as targets of behavioural change interventions. Nat. Rev. Psychol. 3, 377\u2013392 (2024).","journal-title":"Nat. Rev. Psychol."},{"issue":"7","key":"22010_CR45","doi-asserted-by":"publisher","first-page":"e318","DOI":"10.1016\/S2352-3018(16)30063-7","volume":"3","author":"JR Hargreaves","year":"2016","unstructured":"Hargreaves, J. R. et al. The HIV prevention cascade: Integrating theories of epidemiological, behavioural, and social science into programme design and monitoring. Lancet HIV 3(7), e318\u2013e322 (2016).","journal-title":"Lancet HIV"},{"issue":"5","key":"22010_CR46","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s10461-014-0950-5","volume":"19","author":"ET Montgomery","year":"2015","unstructured":"Montgomery, E. T. et al. Male partner influence on women\u2019s HIV prevention trial participation and use of pre-exposure prophylaxis: The importance of \u201cunderstanding\u201d. AIDS Behav. 19(5), 784\u2013793 (2015).","journal-title":"AIDS Behav."},{"issue":"1","key":"22010_CR47","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1186\/s12889-021-10707-x","volume":"21","author":"VA Fonner","year":"2021","unstructured":"Fonner, V. A. et al. \u201cWe are in this together:\u201d Dyadic-level influence and decision-making among HIV serodiscordant couples in Tanzania receiving access to PrEP. BMC Public Health 21(1), 720. https:\/\/doi.org\/10.1186\/s12889-021-10707-x (2021).","journal-title":"BMC Public Health"},{"issue":"1","key":"22010_CR48","first-page":"87","volume":"12","author":"RM Manjate Cuco","year":"2015","unstructured":"Manjate Cuco, R. M. et al. Male partners involvement in prevention of mother-to-child HIV transmission in sub-Saharan Africa: A systematic review. SAHARA J. Soc. Asp. HIV AIDS Res. Alliance 12(1), 87\u2013105 (2015).","journal-title":"SAHARA J. Soc. Asp. HIV AIDS Res. Alliance"},{"issue":"7","key":"22010_CR49","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1080\/13691058.2014.905707","volume":"16","author":"L Parker","year":"2014","unstructured":"Parker, L., Pettifor, A., Maman, S., Sibeko, J. & MacPhail, C. Concerns about partner infidelity are a barrier to adoption of HIV-prevention strategies among young south African couples. Cult. Health Sex 16(7), 792\u2013805 (2014).","journal-title":"Cult. Health Sex"},{"issue":"1","key":"22010_CR50","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12978-019-0749-y","volume":"16","author":"Y Kriel","year":"2019","unstructured":"Kriel, Y. et al. Male partner influence on family planning and contraceptive use: perspectives from community members and healthcare providers in KwaZulu-Natal, south Africa. Reprod. Health 16(1), 89 (2019).","journal-title":"Reprod. Health"},{"issue":"1","key":"22010_CR51","first-page":"41","volume":"25","author":"I Beesham","year":"2021","unstructured":"Beesham, I. et al. Women\u2019s contraceptive choice following the use of Implanon NXT: Findings from a study in Durban south Africa. Afr. J. Reprod. Health 25(1), 41\u201348 (2021).","journal-title":"Afr. J. Reprod. Health"},{"issue":"4","key":"22010_CR52","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/apc.2018.0177","volume":"33","author":"EA Krogstad","year":"2019","unstructured":"Krogstad, E. A. et al. Design of an implant for Long-acting HIV pre-exposure prophylaxis: Input from south African health care providers. AIDS Patient Care STDS. 33(4), 157\u2013166 (2019).","journal-title":"AIDS Patient Care STDS."},{"issue":"11","key":"22010_CR53","doi-asserted-by":"publisher","first-page":"933","DOI":"10.7196\/SAMJ.2017.v107i11.12805","volume":"107","author":"M Pleaner","year":"2017","unstructured":"Pleaner, M. et al. Lessons learnt from the introduction of the contraceptive implant in south Africa. S. Afr. Med. J. 107(11), 933 (2017).","journal-title":"S. Afr. Med. J."},{"issue":"1","key":"22010_CR54","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s43058-020-00105-6","volume":"2","author":"BS Last","year":"2021","unstructured":"Last, B. S. et al. Using behavioral insights to design implementation strategies in public mental health settings: A qualitative study of clinical decision-making. Implement. Sci. Commun. 2(1), 6. https:\/\/doi.org\/10.1186\/s43058-020-00105-6 (2021).","journal-title":"Implement. Sci. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22010-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22010-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22010-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T12:39:45Z","timestamp":1761914385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22010-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22010"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22010-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"1 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Approval for the qualitative sub-study was obtained from the University of KwaZulu-Natal Biomedical Research Ethics Committee (BREC00001785\/2020). Participation was voluntary, and written or electronic informed consent was obtained before completing any study activities. Confidentiality was maintained by anonymising all responses. The study protocol followed the ethical principles and guidelines of The Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participant"}}],"article-number":"38209"}}